Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
898 Ergebnisse
| PL1GHA | Regeneron Pharmaceuticals Inc./OS/Call [1000]/BNP | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,905 % | 0,122 | -0,008 | 7,974 | 18.12.2026 | 0,010 | BNP Paribas | ||
| PL1LRR | Regeneron Pharmaceuticals Inc./OS/Call [1000]/BNP | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,076 % | 0,122 | -0,007 | 7,917 | 15.01.2027 | 0,010 | BNP Paribas | ||
| PL69PF | Regeneron Pharmaceuticals Inc./OS/Call [1000]/BNP | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 72,721 % | 0,120 | -0,020 | 7,775 | 18.09.2026 | 0,010 | BNP Paribas | ||
| PK33WL | Regeneron Pharmaceuticals Inc./OS/Call [1000]/BNP | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,066 % | 0,325 | -0,008 | 3,901 | 17.12.2027 | 0,010 | BNP Paribas | ||
| PK33WK | Regeneron Pharmaceuticals Inc./OS/Call [1000]/BNP | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,612 % | 0,162 | -0,007 | 6,846 | 19.03.2027 | 0,010 | BNP Paribas | ||
| PK51LL | Regeneron Pharmaceuticals Inc./OS/Call [1000]/BNP | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,344 % | 0,341 | -0,008 | 3,725 | 21.01.2028 | 0,010 | BNP Paribas | ||
| PK55E4 | Regeneron Pharmaceuticals Inc./OS/Call [1000]/BNP | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,965 % | 0,365 | -0,008 | 3,471 | 17.03.2028 | 0,010 | BNP Paribas | ||
| PK95YX | Regeneron Pharmaceuticals Inc./OS/Call [1000]/BNP | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,403 % | 0,398 | -0,008 | 3,174 | 16.06.2028 | 0,010 | BNP Paribas | ||
| PM03WY | Regeneron Pharmaceuticals Inc./OS/Call [1000]/BNP | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,543 % | 0,228 | -0,008 | 5,406 | 17.06.2027 | 0,010 | BNP Paribas | ||
| PM5035 | Regeneron Pharmaceuticals Inc./OS/Call [1000]/BNP | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,538 % | 0,277 | -0,008 | 4,541 | 17.09.2027 | 0,010 | BNP Paribas | ||
| GJ50FX | Regeneron Pharmaceuticals Inc./OS/Call [1000]/GOLDS | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 60,785 % | 0,074 | -0,012 | 9,977 | 18.09.2026 | 0,010 | Goldman Sachs | ||
| GJ8XGA | Regeneron Pharmaceuticals Inc./OS/Call [1000]/GOLDS | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,521 % | 0,113 | -0,008 | 8,237 | 18.12.2026 | 0,010 | Goldman Sachs | ||
| GU35T1 | Regeneron Pharmaceuticals Inc./OS/Call [1000]/GOLDS | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,437 % | 0,122 | -0,007 | 7,976 | 15.01.2027 | 0,010 | Goldman Sachs | ||
| GW01FA | Regeneron Pharmaceuticals Inc./OS/Call [1000]/GOLDS | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,058 % | 0,332 | -0,008 | 3,847 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW2Q1Y | Regeneron Pharmaceuticals Inc./OS/Call [1000]/GOLDS | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 76,480 % | 0,068 | -0,017 | 10,354 | 21.08.2026 | 0,010 | Goldman Sachs | ||
| GW43GY | Regeneron Pharmaceuticals Inc./OS/Call [1000]/GOLDS | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,594 % | 0,154 | -0,007 | 6,976 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW80JQ | Regeneron Pharmaceuticals Inc./OS/Call [1000]/GOLDS | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 48,047 % | 0,110 | -0,009 | 8,310 | 20.11.2026 | 0,010 | Goldman Sachs | ||
| GW8Q8X | Regeneron Pharmaceuticals Inc./OS/Call [1000]/GOLDS | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,844 % | 0,370 | -0,007 | 3,468 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| GW8T29 | Regeneron Pharmaceuticals Inc./OS/Call [1000]/GOLDS | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,915 % | 0,201 | -0,007 | 5,918 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GN04WQ | Regeneron Pharmaceuticals Inc./OS/Call [1000]/GOLDS | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,879 % | 0,039 | -0,004 | 12,996 | 16.10.2026 | 0,010 | Goldman Sachs | ||
| MJ3UL2 | Regeneron Pharmaceuticals Inc./OS/Call [1000]/MS | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 47,737 % | 0,140 | -0,010 | 7,264 | 18.12.2026 | 0,010 | Morgan Stanley | ||
| MM7L6V | Regeneron Pharmaceuticals Inc./OS/Call [1000]/MS | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 68,122 % | 0,102 | -0,017 | 8,499 | 18.09.2026 | 0,010 | Morgan Stanley | ||
| MM7L6W | Regeneron Pharmaceuticals Inc./OS/Call [1000]/MS | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,633 % | 0,242 | -0,008 | 5,098 | 17.06.2027 | 0,010 | Morgan Stanley | ||
| MN04NA | Regeneron Pharmaceuticals Inc./OS/Call [1000]/MS | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 44,826 % | 0,346 | -0,009 | 3,640 | 17.12.2027 | 0,010 | Morgan Stanley | ||
| MN6F4F | Regeneron Pharmaceuticals Inc./OS/Call [1000]/MS | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,207 % | 0,184 | -0,008 | 6,193 | 19.03.2027 | 0,010 | Morgan Stanley | ||
| FD442M | Regeneron Pharmaceuticals Inc./OS/Call [1000]/SOC | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,942 % | 0,076 | -0,048 | 10,184 | 18.12.2026 | 0,100 | Société Générale | ||
| FD442H | Regeneron Pharmaceuticals Inc./OS/Call [1000]/SOC | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 45,803 % | 0,022 | -0,031 | 15,399 | 18.09.2026 | 0,100 | Société Générale | ||
| FD48PD | Regeneron Pharmaceuticals Inc./OS/Call [1000]/SOC | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 35,533 % | 0,130 | -0,057 | 7,773 | 19.03.2027 | 0,100 | Société Générale | ||
| FD5DNB | Regeneron Pharmaceuticals Inc./OS/Call [1000]/SOC | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,606 % | 0,197 | -0,067 | 6,010 | 17.06.2027 | 0,100 | Société Générale | ||
| FD5DND | Regeneron Pharmaceuticals Inc./OS/Call [1000]/SOC | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,214 % | 0,294 | -0,071 | 4,338 | 17.12.2027 | 0,100 | Société Générale | ||
| FE23JB | Regeneron Pharmaceuticals Inc./OS/Call [1000]/SOC | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,364 % | 0,311 | -0,071 | 4,134 | 21.01.2028 | 0,100 | Société Générale | ||
| FE5AAH | Regeneron Pharmaceuticals Inc./OS/Call [1000]/SOC | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,891 % | 0,363 | -0,069 | 3,554 | 16.06.2028 | 0,100 | Société Générale | ||
| VJ2MGE | Regeneron Pharmaceuticals Inc./OS/Call [1000]/VONT | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 35,893 % | 0,063 | -0,004 | 10,885 | 18.12.2026 | 0,010 | Vontobel | ||
| VJ2MGS | Regeneron Pharmaceuticals Inc./OS/Call [1000]/VONT | - | - | 1.000,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,171 % | 0,094 | -0,005 | 9,099 | 15.01.2027 | 0,010 | Vontobel | ||
| GJ50FW | Regeneron Pharmaceuticals Inc./OS/Call [1050]/GOLDS | - | - | 1.050,000 | call | Regeneron Pharmaceuticals Inc. | - | 65,749 % | 0,067 | -0,012 | 9,449 | 18.09.2026 | 0,010 | Goldman Sachs | ||
| GW3WD2 | Regeneron Pharmaceuticals Inc./OS/Call [1050]/GOLDS | - | - | 1.050,000 | call | Regeneron Pharmaceuticals Inc. | - | 45,857 % | 0,122 | -0,008 | 7,187 | 15.01.2027 | 0,010 | Goldman Sachs | ||
| GW4REU | Regeneron Pharmaceuticals Inc./OS/Call [1050]/GOLDS | - | - | 1.050,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,908 % | 0,131 | -0,006 | 7,013 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW92TF | Regeneron Pharmaceuticals Inc./OS/Call [1050]/GOLDS | - | - | 1.050,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,864 % | 0,173 | -0,006 | 6,024 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| MJ5C70 | Regeneron Pharmaceuticals Inc./OS/Call [1050]/MS | - | - | 1.050,000 | call | Regeneron Pharmaceuticals Inc. | - | 50,821 % | 0,125 | -0,010 | 7,036 | 18.12.2026 | 0,010 | Morgan Stanley | ||
| MM8YT2 | Regeneron Pharmaceuticals Inc./OS/Call [1050]/MS | - | - | 1.050,000 | call | Regeneron Pharmaceuticals Inc. | - | 73,816 % | 0,096 | -0,017 | 8,005 | 18.09.2026 | 0,010 | Morgan Stanley | ||
| MM8Z6M | Regeneron Pharmaceuticals Inc./OS/Call [1050]/MS | - | - | 1.050,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,262 % | 0,208 | -0,008 | 5,253 | 17.06.2027 | 0,010 | Morgan Stanley | ||
| MN1HGX | Regeneron Pharmaceuticals Inc./OS/Call [1050]/MS | - | - | 1.050,000 | call | Regeneron Pharmaceuticals Inc. | - | 44,899 % | 0,316 | -0,008 | 3,740 | 17.12.2027 | 0,010 | Morgan Stanley | ||
| MN6F4G | Regeneron Pharmaceuticals Inc./OS/Call [1050]/MS | - | - | 1.050,000 | call | Regeneron Pharmaceuticals Inc. | - | 44,306 % | 0,162 | -0,008 | 6,119 | 19.03.2027 | 0,010 | Morgan Stanley | ||
| FD51EX | Regeneron Pharmaceuticals Inc./OS/Call [1050]/SOC | - | - | 1.050,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,767 % | 0,160 | -0,059 | 6,287 | 17.06.2027 | 0,100 | Société Générale | ||
| FE0SQ6 | Regeneron Pharmaceuticals Inc./OS/Call [1050]/SOC | - | - | 1.050,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,878 % | 0,051 | -0,036 | 10,704 | 18.12.2026 | 0,100 | Société Générale | ||
| FE0SQ5 | Regeneron Pharmaceuticals Inc./OS/Call [1050]/SOC | - | - | 1.050,000 | call | Regeneron Pharmaceuticals Inc. | - | 51,989 % | 0,025 | -0,039 | 13,484 | 18.09.2026 | 0,100 | Société Générale | ||
| FE0Y6M | Regeneron Pharmaceuticals Inc./OS/Call [1050]/SOC | - | - | 1.050,000 | call | Regeneron Pharmaceuticals Inc. | - | 34,588 % | 0,090 | -0,042 | 8,550 | 19.03.2027 | 0,100 | Société Générale | ||
| PK33WG | Regeneron Pharmaceuticals Inc./OS/Call [1100]/BNP | - | - | 1.100,000 | call | Regeneron Pharmaceuticals Inc. | - | 58,960 % | 0,143 | -0,012 | 6,024 | 18.12.2026 | 0,010 | BNP Paribas | ||
| PK5ZKH | Regeneron Pharmaceuticals Inc./OS/Call [1100]/BNP | - | - | 1.100,000 | call | Regeneron Pharmaceuticals Inc. | - | 53,522 % | 0,144 | -0,010 | 6,078 | 15.01.2027 | 0,010 | BNP Paribas | ||
| GJ50FS | Regeneron Pharmaceuticals Inc./OS/Call [1100]/GOLDS | - | - | 1.100,000 | call | Regeneron Pharmaceuticals Inc. | - | 70,859 % | 0,062 | -0,012 | 8,940 | 18.09.2026 | 0,010 | Goldman Sachs |